Institute of Social and Preventive Medicine, University of Bern, Bern CH-3012, Switzerland.
Sex Transm Infect. 2011 Dec;87(7):601-8. doi: 10.1136/sextrans-2011-050205. Epub 2011 Oct 25.
To describe, using routine data in selected countries, chlamydia control activities and rates of chlamydia infection, pelvic inflammatory disease (PID), ectopic pregnancy and infertility and to compare trends in chlamydia positivity with rates of PID and ectopic pregnancy.
Cross-national comparison including national data from Australia, Denmark, the Netherlands, New Zealand, Sweden and Switzerland. Routine data sources about chlamydia diagnosis and testing and International Classification of Disease-10 coded diagnoses of PID, ectopic pregnancy and infertility in women aged 15-39 years from 1999 to 2008 were described. Trends over time and relevant associations were examined using Poisson regression.
Opportunistic chlamydia testing was recommended in all countries except Switzerland, but target groups differed. Rates of chlamydia testing were highest in New Zealand. Chlamydia positivity was similar in all countries with available data (Denmark, New Zealand and Sweden) and increased over time. Increasing chlamydia positivity rates were associated with decreasing PID rates in Denmark and Sweden and with decreasing ectopic pregnancy rates in Denmark, New Zealand and Sweden. Ectopic pregnancy rates appeared to increase over time in 15-19-year-olds in several countries. Trends in infertility diagnoses were very variable.
The intensity of recommendations about chlamydia control varied between countries but was not consistently related to levels of chlamydia diagnosis or testing. Relationships between levels of chlamydia infection and complication rates between or within countries over time were not straightforward. Development and validation of indicators of chlamydia-related morbidity that can be compared across countries and over time should be pursued.
利用选定国家的常规数据,描述衣原体控制活动和衣原体感染率、盆腔炎(PID)、宫外孕和不孕率,并比较衣原体阳性率与 PID 和宫外孕发生率的趋势。
包括澳大利亚、丹麦、荷兰、新西兰、瑞典和瑞士的国家数据在内的跨国比较。描述了 1999 年至 2008 年间 15-39 岁女性的衣原体诊断和检测的常规数据来源,以及国际疾病分类-10 编码的 PID、宫外孕和不孕的诊断。使用泊松回归检验随时间的趋势和相关关联。
除瑞士外,所有国家都建议进行机会性衣原体检测,但目标人群不同。新西兰的衣原体检测率最高。在有数据的所有国家(丹麦、新西兰和瑞典),衣原体阳性率相似,且随时间推移而增加。在丹麦和瑞典,衣原体阳性率的增加与 PID 率的降低有关,在丹麦、新西兰和瑞典,与宫外孕率的降低有关。在几个国家,15-19 岁青少年的宫外孕率似乎随时间增加。不孕诊断的趋势差异很大。
各国关于衣原体控制的建议强度有所不同,但与衣原体诊断或检测水平不一致。衣原体感染水平与并发症发生率之间的关系,无论是在国家之间还是在国家内部,随时间推移都不简单。应努力制定和验证可以在国家之间和随时间推移进行比较的衣原体相关发病率指标。